<DOC>
	<DOCNO>NCT01445613</DOCNO>
	<brief_summary>The objective CANOPY trial ass continue safety effectiveness RX Acculink Carotid Stent System commercial use subject standard risk adverse event Carotid Endarterectomy ( CEA ) enrol physician range carotid stenting experience .</brief_summary>
	<brief_title>Carotid Artery Stenting Outcomes Standard Risk Population Carotid Endarterectomy</brief_title>
	<detailed_description />
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Blindness</mesh_term>
	<mesh_term>Amaurosis Fugax</mesh_term>
	<criteria>1 . Subject must ≥ 18 year age . 2 . Subject condition limit anticipate survival le 3 year . 3 . Subject legally authorize representative must provide write informed consent prior trial related procedure . 4 . Subjects neurological symptom within 180 day procedure ≥ 70 % stenosis common internal carotid artery ultrasound ≥ 50 % stenosis common internal carotid artery angiogram OR 5 . Subjects without neurological symptom within 180 day procedure ≥ 70 % stenosis common internal carotid artery ultrasound ≥ 60 % stenosis common internal carotid artery angiogram . 6 . Subject follow target vessel characteristic : 1 . Discrete lesion internal carotid artery ( ICA ) without involvement contiguous common carotid artery ( CCA ) . 2 . Vessel diameter ≥ 4.0 mm ≤ 9.0 mm reference contralateral artery . 3 . Absence excessive vessel tortuosity would impede delivery device . 7 . Subject must agree participate clinical trial period 1 year follow index procedure . 1 . Subjects anatomic clinical condition make high risk adverse event carotid endarterectomy ( CEA ) . 2 . Subject Hgb &lt; 10.g/dl platelet count &lt; 125,000 µl heparinassociated thrombocytopenia . For subject Coumadin ( Warfarin ) subject platelet coagulation disorder : Has international normalize ratio ( INR ) &gt; 1.5 . 3 . Subject active bleeding diathesis coagulopathy subject would refuse blood transfusion . 4 . Subject currently list major organ transplantation ( i.e. , heart , lung , liver , kidney ) evaluate . 5 . Subject currently participate another clinical trial yet complete primary endpoint . 6 . Pregnant nursing subject plan pregnancy period 1 year follow index procedure . Female subject childbearing potential must negative pregnancy test do within 7 day prior index procedure per site standard test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Carotid</keyword>
	<keyword>Stent</keyword>
	<keyword>Carotid Endarterectomy</keyword>
</DOC>